FLAX SEED PWS 1000MG/GM 1 G
LINUM USITATISSIMUM : 1 G · DIN 00827118 · OMEGA NUTRITION CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is FLAX SEED PWS 1000MG/GM?
FLAX SEED PWS 1000MG/GM 1 G contains LINUM USITATISSIMUM : 1 G. It is listed in the Health Canada Drug Product Database under DIN 00827118, held by OMEGA NUTRITION CANADA INC., supplied as POWDER FOR SOLUTION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 22-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00827118 |
|---|---|
| Brand name | FLAX SEED PWS 1000MG/GM |
| Generic / active ingredient | LINUM USITATISSIMUM : 1 G |
| Manufacturer | OMEGA NUTRITION CANADA INC. |
| Strength | 1 G |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AC05 LINSEED |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 22-Aug-1997 |
| Original market date | 1990-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AC05 LINSEED. 0 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| GRAINE DE LIN | 100 % | SEED | PRODUITS MARC-O (1987) INC., DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00430838 |
| GRAINE DE LIN | 100 % | SEED | LAB VALMO ENREGISTRÉ, DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00485810 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.